{"id":34040,"date":"2025-05-23T22:46:28","date_gmt":"2025-05-23T14:46:28","guid":{"rendered":"https:\/\/flcube.com\/?p=34040"},"modified":"2025-05-23T22:46:29","modified_gmt":"2025-05-23T14:46:29","slug":"meinian-onehealth-partners-with-alibaba-damo-academy-for-ai-driven-disease-screening","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=34040","title":{"rendered":"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening"},"content":{"rendered":"\n

China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044<\/a>) has entered into a partnership with The Academy for Discovery, Adventure, Momentum and Outlook (Alibaba DAMO Academy). The collaboration aims to leverage DAMO Academy\u2019s proprietary “One Scan, Multiple Detections” medical AI technology to jointly advance screening for critical diseases such as cancer and chronic conditions, while also exploring innovations in intelligent health checkup services.<\/p>\n\n\n\n

DAMO Academy’s AI Technology<\/strong>
DAMO Academy, Alibaba Group\u2019s premier research and talent hub, pioneered the groundbreaking “One Scan, Multiple Detections” AI technology. This innovation utilizes a single non-contrast CT scan to identify multiple subtle lesions that are undetectable by the human eye. The technology has been deployed for pancreatic cancer, esophageal cancer, gastric cancer, colorectal cancer, liver cancer, and other cancers, as well as chronic diseases like osteoporosis, fatty liver, and emergencies such as aortic syndrome.<\/p>\n\n\n\n

Collaboration Goals<\/strong>
Through this partnership, Meinian Onehealth and DAMO Academy will work together to enhance the efficiency and accuracy of disease screening. The collaboration will also focus on developing intelligent health checkup services, leveraging the power of AI to improve early detection and treatment of critical diseases.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a partnership with…<\/p>\n","protected":false},"author":1,"featured_media":34041,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[16,87,1634,1633],"class_list":["post-34040","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-cancer","tag-chronic-disease","tag-meinian-onehealth-healthcare","tag-she-002044"],"yoast_head":"\nMeinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a partnership with The Academy for Discovery, Adventure, Momentum and Outlook (Alibaba DAMO Academy). The collaboration aims to leverage DAMO Academy\u2019s proprietary "One Scan, Multiple Detections" medical AI technology to jointly advance screening for critical diseases such as cancer and chronic conditions, while also exploring innovations in intelligent health checkup services.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=34040\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening\" \/>\n<meta property=\"og:description\" content=\"China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a partnership with The Academy for Discovery, Adventure, Momentum and Outlook (Alibaba DAMO Academy). The collaboration aims to leverage DAMO Academy\u2019s proprietary "One Scan, Multiple Detections" medical AI technology to jointly advance screening for critical diseases such as cancer and chronic conditions, while also exploring innovations in intelligent health checkup services.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=34040\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-23T14:46:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-23T14:46:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2302-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34040#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34040\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening\",\"datePublished\":\"2025-05-23T14:46:28+00:00\",\"dateModified\":\"2025-05-23T14:46:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34040\"},\"wordCount\":203,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34040#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2302-1.webp\",\"keywords\":[\"Cancer\",\"Chronic disease\",\"Meinian Onehealth Healthcare\",\"SHE: 002044\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34040#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34040\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=34040\",\"name\":\"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34040#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34040#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2302-1.webp\",\"datePublished\":\"2025-05-23T14:46:28+00:00\",\"dateModified\":\"2025-05-23T14:46:29+00:00\",\"description\":\"China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a partnership with The Academy for Discovery, Adventure, Momentum and Outlook (Alibaba DAMO Academy). The collaboration aims to leverage DAMO Academy\u2019s proprietary \\\"One Scan, Multiple Detections\\\" medical AI technology to jointly advance screening for critical diseases such as cancer and chronic conditions, while also exploring innovations in intelligent health checkup services.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34040#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34040\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34040#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2302-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2302-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34040#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening - Insight, China's Pharmaceutical Industry","description":"China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a partnership with The Academy for Discovery, Adventure, Momentum and Outlook (Alibaba DAMO Academy). The collaboration aims to leverage DAMO Academy\u2019s proprietary \"One Scan, Multiple Detections\" medical AI technology to jointly advance screening for critical diseases such as cancer and chronic conditions, while also exploring innovations in intelligent health checkup services.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=34040","og_locale":"en_US","og_type":"article","og_title":"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening","og_description":"China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a partnership with The Academy for Discovery, Adventure, Momentum and Outlook (Alibaba DAMO Academy). The collaboration aims to leverage DAMO Academy\u2019s proprietary \"One Scan, Multiple Detections\" medical AI technology to jointly advance screening for critical diseases such as cancer and chronic conditions, while also exploring innovations in intelligent health checkup services.","og_url":"https:\/\/flcube.com\/?p=34040","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-05-23T14:46:28+00:00","article_modified_time":"2025-05-23T14:46:29+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2302-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=34040#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=34040"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening","datePublished":"2025-05-23T14:46:28+00:00","dateModified":"2025-05-23T14:46:29+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=34040"},"wordCount":203,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=34040#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2302-1.webp","keywords":["Cancer","Chronic disease","Meinian Onehealth Healthcare","SHE: 002044"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=34040#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=34040","url":"https:\/\/flcube.com\/?p=34040","name":"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=34040#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=34040#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2302-1.webp","datePublished":"2025-05-23T14:46:28+00:00","dateModified":"2025-05-23T14:46:29+00:00","description":"China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a partnership with The Academy for Discovery, Adventure, Momentum and Outlook (Alibaba DAMO Academy). The collaboration aims to leverage DAMO Academy\u2019s proprietary \"One Scan, Multiple Detections\" medical AI technology to jointly advance screening for critical diseases such as cancer and chronic conditions, while also exploring innovations in intelligent health checkup services.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=34040#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=34040"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=34040#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2302-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2302-1.webp","width":1080,"height":608,"caption":"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=34040#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2302-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=34040"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34040\/revisions"}],"predecessor-version":[{"id":34042,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34040\/revisions\/34042"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/34041"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=34040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=34040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=34040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}